10 results
8-K
EX-10.1
IPSC
Century Therapeutics Inc
11 Apr 24
Completion of Acquisition or Disposition of Assets
5:25pm
of any principal supplier, manufacturer, customer or contractor of the Company, exists or, to the Company’s Knowledge, is threatened or imminent.
4.14
10-K
2021 FY
IPSC
Century Therapeutics Inc
17 Mar 22
Annual report
5:01pm
clinical supplier for the first NK cell product candidate for which we submit an IND and that FCDI will have the option to be our exclusive clinical … supplier for certain of our next three or four product candidates for which we may submit an IND, depending on whether they are NK cell product
10-Q
2021 Q2
IPSC
Century Therapeutics Inc
12 Aug 21
Quarterly report
10:05am
any of these suppliers, which could be due to the impacts of the COVID-19 pandemic, regulatory actions, or requirements affecting the supplier, adverse … financial or other strategic developments experienced by a supplier, labor disputes or shortages, unexpected demands, or quality issues, could
424B4
IPSC
Century Therapeutics Inc
21 Jun 21
Prospectus supplement with pricing info
6:02am
pandemic, regulatory actions, or requirements affecting the supplier, adverse financial or other strategic developments experienced by a supplier … clinical supplier for the first NK cell product candidate for which we submit an IND and that FCDI will have the option to be our exclusive clinical
S-1/A
zsct9s
14 Jun 21
IPO registration (amended)
6:06am
S-1
EX-10.25
tcoxz7tzf7lsihcc5vew
28 May 21
IPO registration
5:01pm
S-1
f9hjc
28 May 21
IPO registration
5:01pm
DRS
06gc9e4y py2yop3q1
26 Mar 21
Draft registration statement
12:00am
- Prev
- 1
- Next